Back to top

Image: Bigstock

Veeva Systems Inc.

Read MoreHide Full Article

Veeva Systems exited fiscal 2018 on a solid note with both revenues and earnings beating the consensus mark. We are encouraged by Veeva Systems’ consistent efforts in product innovation and launches through R&D. Growing global demand for cloud-based and vault applications also boost opportunities. Veeva Systems’ product unveilings and its industry-focused approach hold promise. We are currently looking forward to the company’s deal with two top 10 pharmaceutical companies. These partnerships will expand usage of Veeva CRM in the emerging markets. However, high expenses on the operational side are causing a drag on the company’s margins, partially dampening its revenues. Furthermore, intensifying competition and a saturating life sciences market are key concerns. Volatility in foreign currency exchange rate is a headwind.


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Veeva Systems Inc. (VEEV) - free report >>

Published in